홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

Prednisolone Phosphate

HCID 72078
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
302-25-0
표준 SMILES
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)(O)O
InChIKey
JDOZJEUDSLGTLU-VWUMJDOOSA-N
분자식
C21H29O8P
평균 분자량
440.4 g/mol
단동위원소 질량
440.16000488

개요

Prednisolone sodium phosphate can cause developmental toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Prednisolone Phosphate
IUPAC
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate
영어명
11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)
분자식
C21H29O8P
분자량
440.42

이름 및 동의어

Prednisolone phosphate302-25-0PREDNISOLONE 21-PHOSPHATEprednisolone 21-monophosphatePrednisolone 21-(dihydrogen phosphate)752SY38R6CDTXSID7047481CHEBI:145705{2-[(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethoxy}phosphonic acid(2-((1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta(a)phenanthren-1-yl)-2-oxoethoxy)phosphonic acidRefChem:868418DTXCID5027481
이름 더 보기
PSLP11β,17-Dihydroxy-21-(phosphonooxy)pregna-1,4-diene-3,20-dione11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-phosphoric acidPregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, (11β)-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] dihydrogen phosphate

물성

구조 계산 물성

XLogP
0
극성 표면적
141 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
8
회전 가능 결합 수
4
무거운 원자 수
30
형식 전하
0
복잡도
889

실험 및 물리화학적 성질

Endocrine DisruptorsPotential endocrine disrupting compound

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H360 (33.3%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P260, P280, P318, P319, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationREACH registered substance: 11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) (EC: 206-120-1)
Hazard Classes and CategoriesRepr. 1B (33.3%)

안전 데이터

신호 어
Danger
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H360

화학 및 산업

약리 정보

Protein BindingPrednisolone is 70-90% protein bound in plasma. Prednisolone typically binds to albumin and corticosteroid binding globulin.
Pharmacodynamics · 1건

Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals. Prednisolone has a short duration of action as the half life is 2-4 hours. Corticosteroids have a wide therapeutic window as patients make require doses that are multiples of what the body naturally produces. Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.

Mechanism of Action · 1건

The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation. Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days. Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10. Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive. High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.

Biological Half-LifeThe half life of prednisolone is 2-4 hours.
Metabolism/MetabolitesPrednisolone phosphate undergoes ester hydrolysis to [prednisolone]. After this step, the drug undergoes the normal metabolism of prednisolone.
MeSH Pharmacological Classification · 1건

A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] dihydrogen phosphate
206-120-1[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate11beta,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl dihydrogen phosphatePrednisolone Phosphoric AcidUNII-752SY38R6C11,17-dihydroxy-21-(phosphonooxy)-Pregna-1,4-diene-3,20-dioneEINECS 206-120-111beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)

데이터베이스 식별자

CAS
302-25-0
PubChem CID
72078
DTXSID
DTXSID7047481
ChEMBL
CHEMBL1201231
ChEBI
CHEBI:145705
UNII
752SY38R6C
EC Number
206-120-1
Nikkaji
J193.710C
Absorption, Distribution and Excretion · 3건

A 30mg prednisolone oral solution reaches a Cmax of 461.33±77.94ng/mL with an AUC of 2426.1±360.0ng\*h/mL. A 30mg prednisolone orally disintegrating tablet reaches a Cmax of 420.91±78.28ng/mL with an AUC of 2408.1±361.5ng\*h/mL.

Prednisolone is predominantly eliminated in the urine as sulfate and glucuronide conjugate metabolites.

The volume of distribution of prednisolone phosphate has been reported as 0.22-0.7L/kg.

응용 분야

용도Glucocorticoid.

공급사6 곳

湖北瑞玛标物科技有限公司15787879035 15787875101 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
深圳卓越生物医药科技有限公司26050679 18318671572 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]